Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42.9M
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
47.1M
-
Shares change
-
+42K
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
-$16.6M
-
Put/Call ratio
-
0.78
-
Number of buys
-
130
-
Number of sells
-
-121
-
Price
-
$30.68
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2023
302 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.1M shares
.
Largest 10 shareholders include BlackRock Inc. (7.51M shares), VANGUARD GROUP INC (4.96M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.8M shares), STATE STREET CORP (1.79M shares), MACQUARIE GROUP LTD (1.66M shares), BAILLIE GIFFORD & CO (1.64M shares), RENAISSANCE TECHNOLOGIES LLC (1.61M shares), DIMENSIONAL FUND ADVISORS LP (1.39M shares), Stephens Investment Management Group LLC (1.34M shares), and Prosight Management, LP (1.21M shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.